Patents by Inventor Abhijeet Nag
Abhijeet Nag has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20100305174Abstract: The present invention relates to novel heterocyclic derivatives of formula (I) and their pharmaceutically acceptable salts, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their hydrates, their solvates, their pharmaceutically acceptable salts, their pharmaceutical compositions, and their prodrugs thereof. The present invention more particularly provides novel compounds of the general formula (1).Type: ApplicationFiled: April 12, 2006Publication date: December 2, 2010Applicant: ORCHID RESEARCH LABORATORIES LIMITEDInventors: Surendrakumar Satyanarayan Pandey, Gadam Om Reddy, Shiv Kumar Agarwal, Gajendra Singh, Santhanagopalan Chithra, Debendranath Dey, Abhijeet Nag, Kadnur Venkatachalapathi Sanjay
-
Patent number: 7781464Abstract: The present invention relates to novel heterocyclic diphenyl ether and diphenyl amine compounds, derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts and pharmaceutically acceptable solvates thereof and pharmaceutically acceptable compositions containing these singly or in combination. The compounds of the present invention are effective in lowering blood glucose, serum insulin, free fatty acids, cholesterol and triglyceride levels and are useful in the treatment and/or prophylaxis of diabetes. The compounds of the present invention are effective in treatment of obesity, inflammation, autoimmune diseases such as multiple sclerosis and rheumatoid arthritis and immunological diseases, including the treatment of cancer. Furthermore, the compounds are useful for the treatment of disorders associated with insulin resistance.Type: GrantFiled: February 21, 2006Date of Patent: August 24, 2010Assignee: Bexel Pharmaceuticals, Inc.Inventors: Partha Neogi, Bishwajit Nag, Debendranath Dey, Abhijeet Nag, Birendra Kumar Bhattacharya, Vinod Kumar Singh, Surendradoss Jayakumar
-
Patent number: 7521465Abstract: Novel diphenyl ether derivatives are provided that exhibit activity useful for reducing glucose, cholesterol, and/or triglyceride levels in plasma, and for treatment of obesity, inflammation, immunological diseases, autoimmune diseases, diabetes and disorders associated with insulin resistance.Type: GrantFiled: March 31, 2005Date of Patent: April 21, 2009Assignee: Bexel Pharmaceuticals, Inc.Inventors: Bishwajit Nag, Abhijeet Nag, Debendranath Dey, Shiv Kumar Agarwal, Partha Neogi, Gaddam Om Reddy, Sangamesh Badiger, Gajendra Singh, Surendra Kumar Pandey, Santhanagopalan Chithra
-
Patent number: 7521466Abstract: Novel dipeptide ethers are effective for lowering blood glucose, serum insulin, free fatty acids, cholesterol and triglyceride levels. The dipeptide ethers are also useful for the treatment and/or prophylaxis of diabetes, obesity, inflammation and autoimmune diseases such as multiple sclerosis and rheumatoid arthritis.Type: GrantFiled: May 4, 2006Date of Patent: April 21, 2009Assignee: Bexel Pharmaceuticals, Inc.Inventors: Bishwajit Nag, Abhijeet Nag, Debendranath Dey, Partha Neogi, Shiv Kumar Agarwal, Surendra Kumar Pandey
-
Publication number: 20080319031Abstract: The present invention relates to novel tyrosine derivatives of formula (I), their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention more particularly provides novel tyrosine derivatives of the general formula (I).Type: ApplicationFiled: March 10, 2006Publication date: December 25, 2008Inventors: Surendrakumar Satyanarayan Pandey, Shiv Kumar Agarwal, Gajendra Singh, Santhanagopalan Chithra, Sangmesh Badiger, Bishwajit Nag, Debendranath Dey, Abhijeet Nag, Partha Neogi
-
Publication number: 20080267888Abstract: The present invention relates to novel heterocyclic derivatives of the general formula (I), their pharmaceutically acceptable salts and compositions, their analogs, their tautomeric forms, and their stereoisomers. The present invention more particularly provides novel compounds of the general formula (I).Type: ApplicationFiled: May 25, 2006Publication date: October 30, 2008Inventors: Surendrakumar Satyanarayan Pandey, Gaddam Om Reddy, Gajendra Singh, Chitra Santhanagopalan, Sanjay Venkatachalapathi Kadnur, Debendranath Dey, Abhijeet Nag
-
Publication number: 20070037863Abstract: Novel dipeptide ethers are effective for lowering blood glucose, serum insulin, free fatty acids, cholesterol and triglyceride levels. The dipeptide ethers are also useful for the treatment and/or prophylaxis of diabetes, obesity, inflammation and autoimmune diseases such as multiple sclerosis and rheumatoid arthritis.Type: ApplicationFiled: May 4, 2006Publication date: February 15, 2007Inventors: Bishwajit Nag, Abhijeet Nag, Debendranath Dey, Partha Neogi, Shiv Agarwal, Surendra Pandey
-
Publication number: 20060247285Abstract: The present invention relates to novel heterocyclic diphenyl ether and diphenyl amine compounds, derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts and pharmaceutically acceptable solvates thereof and pharmaceutically acceptable compositions containing these singly or in combination. The compounds of the present invention are effective in lowering blood glucose, serum insulin, free fatty acids, cholesterol and triglyceride levels and are useful in the treatment and/or prophylaxis of diabetes. The compounds of the present invention are effective in treatment of obesity, inflammation, autoimmune diseases such as multiple sclerosis and rheumatoid arthritis and immunological diseases, including the treatment of cancer. Furthermore, the compounds are useful for the treatment of disorders associated with insulin resistance.Type: ApplicationFiled: February 21, 2006Publication date: November 2, 2006Inventors: Partha Neogi, Bishwajit Nag, Debendranath Dey, Abhijeet Nag, Birendra Bhattacharya, Vinod Singh, Surendradoss Jayakumar
-
Patent number: 7087576Abstract: Novel dipeptide ethers are effective for lowering blood glucose, serum insulin, free fatty acids, cholesterol and triglyceride levels. The dipeptide ethers are also useful for the treatment and/or prophylaxis of diabetes, obesity, inflammation and autoimmune diseases such as multiple sclerosis and rheumatoid arthritis.Type: GrantFiled: October 7, 2003Date of Patent: August 8, 2006Assignee: Bexel Pharmaceuticals, Inc.Inventors: Bishwajit Nag, Abhijeet Nag, Debendranath Dey, Partha Neogi, Shiv Kumar Agarwal, Surendra Kumar Pandey
-
Publication number: 20050288341Abstract: Novel diphenyl ether derivatives are provided that exhibit activity useful for reducing glucose, cholesterol, and/or triglyceride levels in plasma, and for treatment of obesity, inflammation, immunological diseases, autoimmune diseases, diabetes and disorders associated with insulin resistance.Type: ApplicationFiled: March 31, 2005Publication date: December 29, 2005Inventors: Bishwajit Nag, Abhijeet Nag, Debendranath Dey, Shiv Agarwal, Partha Neogi, Gaddam Reddy, Sangamesh Badiger, Gajendra Singh, Surendra Pandey, Santhanagopalan Chithra
-
Publication number: 20050096366Abstract: Novel amino acid phenyl ethers are provided which exhibit activity for the treatment of immunological diseases, inflammation, obesity, hyperlipidemia, hypertension, neurological diseases and diabetes.Type: ApplicationFiled: September 21, 2004Publication date: May 5, 2005Inventors: Bishwajit Nag, Abhijeet Nag, Debendranath Dey, Shiv Agarwal
-
Publication number: 20050075293Abstract: Novel dipeptide ethers are effective for lowering blood glucose, serum insulin, free fatty acids, cholesterol and triglyceride levels. The dipeptide ethers are also useful for the treatment and/or prophylaxis of diabetes, obesity, inflammation and autoimmune diseases such as multiple sclerosis and rheumatoid arthritis.Type: ApplicationFiled: October 7, 2003Publication date: April 7, 2005Inventors: Bishwajit Nag, Abhijeet Nag, Debendranath Dey, Partha Neogi
-
Patent number: 6794401Abstract: Novel amino acid phenyl ethers are provided which exhibit activity for the treatment of immunological diseases, inflammation, obesity, hyperlipidemia, hypertension, neurological diseases and diabetes.Type: GrantFiled: January 31, 2003Date of Patent: September 21, 2004Assignee: Bexel Pharmaceuticals, Inc.Inventors: Bishwajit Nag, Abhijeet Nag, Debendranath Dey, Shiv Kumar Agarwal
-
Publication number: 20040142991Abstract: Novel amino acid phenyl ethers are provided which exhibit activity for the treatment of immunological diseases, inflammation, obesity, hyperlipidemia, hypertension, neurological diseases and diabetes.Type: ApplicationFiled: January 31, 2003Publication date: July 22, 2004Inventors: Bishwajit Nag, Abhijeet Nag, Debendranath Dey, Shiv Kumar Agarwal